[1-[5,6-dimethyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)-2-pyridinyl]-4-[(2-methylcyclohexyl)amino]piperidin-3-yl]methanol
C23H35N5O2 — CID 118263788
Data last refreshed: (MolForge compound catalog, from PubChem)
About [1-[5,6-dimethyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)-2-pyridinyl]-4-[(2-methylcyclohexyl)amino]piperidin-3-yl]methanol
[1-[5,6-dimethyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)-2-pyridinyl]-4-[(2-methylcyclohexyl)amino]piperidin-3-yl]methanol (PubChem CID 118263788) has the molecular formula C23H35N5O2 and a molecular weight of 413.57 g/mol. Its IUPAC name is [1-[5,6-dimethyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)-2-pyridinyl]-4-[(2-methylcyclohexyl)amino]piperidin-3-yl]methanol.
Molecular Properties
| Compound Name | [1-[5,6-dimethyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)-2-pyridinyl]-4-[(2-methylcyclohexyl)amino]piperidin-3-yl]methanol |
|---|---|
| PubChem CID | 118263788 |
| Molecular Formula | C23H35N5O2 |
| Molecular Weight | 413.57 g/mol |
| Exact Mass | 413.28 |
| IUPAC Name | [1-[5,6-dimethyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)-2-pyridinyl]-4-[(2-methylcyclohexyl)amino]piperidin-3-yl]methanol |
| SMILES | Cc1noc(-c2cc(C)c(C)nc2N2CCC(NC3CCCCC3C)C(CO)C2)n1 |
| InChI | InChI=1S/C23H35N5O2/c1-14-7-5-6-8-20(14)26-21-9-10-28(12-18(21)13-29)22-19(11-15(2)16(3)24-22)23-25-17(4)27-30-23/h11,14,18,20-21,26,29H,5-10,12-13H2,1-4H3 |
| InChIKey | RHOCANMSAKRZNP-UHFFFAOYSA-N |
| XLogP | 3.41 |
| TPSA | 87.31 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 413.57 |
| LogP ≤ 5 | 3.41 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118263788 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.